155 related articles for article (PubMed ID: 35961103)
1. Reprogramming of dermal fibroblasts from a Duchenne muscular dystrophy patient carrying a deletion of exons 45-50 into an induced pluripotent stem cell line (CCMi005-A).
Rovina D; Castiglioni E; Mallia S; Rabino M; Farini A; Belicchi M; Di Giuseppe G; Gervasini C; Torrente Y; Pompilio G; Gowran A
Stem Cell Res; 2022 Oct; 64():102889. PubMed ID: 35961103
[TBL] [Abstract][Full Text] [Related]
2. Establishment of a Duchenne muscular dystrophy patient-derived induced pluripotent stem cell line carrying a deletion of exons 51-53 of the dystrophin gene (CCMi003-A).
Rovina D; Castiglioni E; Farini A; Bellichi M; Gervasini C; Paganini S; Di Segni M; Santoro R; Torrente Y; Pompilio G; Gowran A
Stem Cell Res; 2019 Oct; 40():101544. PubMed ID: 31465894
[TBL] [Abstract][Full Text] [Related]
3. Derivation of the Duchenne muscular dystrophy patient-derived induced pluripotent stem cell line lacking DMD exons 49 and 50 (CCMi001DMD-A-3, ∆49, ∆50).
Spaltro G; Vigorelli V; Casalnuovo F; Spinelli P; Castiglioni E; Rovina D; Paganini S; Di Segni M; Nigro P; Gervasini C; Pompilio G; Gowran A
Stem Cell Res; 2017 Dec; 25():128-131. PubMed ID: 29127875
[TBL] [Abstract][Full Text] [Related]
4. Generation of Duchenne muscular dystrophy patient-specific induced pluripotent stem cell line lacking exons 45-50 of the dystrophin gene (IITi001-A).
Eisen B; Ben Jehuda R; Cuttitta AJ; Mekies LN; Reiter I; Ramchandren S; Arad M; Michele DE; Binah O
Stem Cell Res; 2018 May; 29():111-114. PubMed ID: 29653394
[TBL] [Abstract][Full Text] [Related]
5. Generation of induced pluripotent stem cells from a Becker muscular dystrophy patient carrying a deletion of exons 45-55 of the dystrophin gene (CCMi002BMD-A-9 ∆45-55).
Gowran A; Spaltro G; Casalnuovo F; Vigorelli V; Spinelli P; Castiglioni E; Rovina D; Paganini S; Di Segni M; Gervasini C; Nigro P; Pompilio G
Stem Cell Res; 2018 Apr; 28():21-24. PubMed ID: 29414413
[TBL] [Abstract][Full Text] [Related]
6. Establishment of a human iPSC line XMDYYYi001-A from a patient with Becker muscular dystrophy harboring duplications of exons 2-19 in dystrophin gene.
Wang D; Lin J; Jin M; Wang N
Stem Cell Res; 2021 May; 53():102298. PubMed ID: 33799273
[TBL] [Abstract][Full Text] [Related]
7. Generation and characterization of an induced pluripotent stem cell line (FJMUNi001-A) from a patient with Duchenne muscular dystrophy carrying c.4518 + 512 T > A variant in the DMD gene.
Jin M; Wang D; Li G; Lin J; Lin X; Wang N
Stem Cell Res; 2022 Apr; 60():102718. PubMed ID: 35247844
[TBL] [Abstract][Full Text] [Related]
8. Generation of three Duchenne muscular dystrophy patient-derived induced pluripotent stem cell (iPSC) lines ICGi002-A, ICGi002-B and ICGi002-C.
Valetdinova KR; Maretina MA; Vyatkin YV; Perepelkina MP; Egorova AA; Baranov VS; Kiselev AV; Gershovich PM; Zakian SM
Stem Cell Res; 2020 Oct; 48():101941. PubMed ID: 32777771
[TBL] [Abstract][Full Text] [Related]
9. Generation of the Becker muscular dystrophy patient derived induced pluripotent stem cell line carrying the DMD splicing mutation c.1705-8 T>C.
Rovina D; Castiglioni E; Niro F; Farini A; Belicchi M; Di Fede E; Gervasini C; Paganini S; Di Segni M; Torrente Y; Santoro R; Pompilio G; Gowran A
Stem Cell Res; 2020 May; 45():101819. PubMed ID: 32348941
[TBL] [Abstract][Full Text] [Related]
10. Reprogramming of human Peripheral Blood Mononuclear Cell (PBMC) from a Chinese patient suffering Duchenne muscular dystrophy to iPSC line (SDQLCHi007-A) carrying deletion of 49-50 exons in the DMD gene.
Guan J; Liu X; Zhang H; Yang X; Ma Y; Li Y; Gai Z; Liu Y
Stem Cell Res; 2020 Jan; 42():101666. PubMed ID: 31812072
[TBL] [Abstract][Full Text] [Related]
11. Generation of two Duchenne muscular dystrophy patient-specific induced pluripotent stem cell lines DMD02 and DMD03 (MUNIi001-A and MUNIi003-A).
Jelinkova S; Markova L; Pesl M; Valáškova I; Makaturová E; Jurikova L; Vondracek P; Lacampagne A; Dvorak P; Meli AC; Rotrekl V
Stem Cell Res; 2019 Oct; 40():101562. PubMed ID: 31526943
[TBL] [Abstract][Full Text] [Related]
12. Generation of two induced pluripotent stem cell lines from Duchenne muscular dystrophy patients.
Liu W; Zeng W; Kong X; Htet M; Yu R; Wheeler M; Day JW; Wu JC
Stem Cell Res; 2023 Oct; 72():103207. PubMed ID: 37740996
[TBL] [Abstract][Full Text] [Related]
13. Generation and characterization of an induced pluripotent stem cell line (ZSYYDNi001-A) from a patient with Duchenne muscular dystrophy carrying exon 51 deletion in the DMD gene.
Wang L; Li H; Li Y; Xu M; Lin J; Liao Z; Pei Z; Zhang C
Stem Cell Res; 2021 Oct; 56():102553. PubMed ID: 34619646
[TBL] [Abstract][Full Text] [Related]
14. Targeted addition of mini-dystrophin into rDNA locus of Duchenne muscular dystrophy patient-derived iPSCs.
Zeng B; Zhou M; Liu B; Shen F; Xiao R; Su J; Hu Z; Zhang Y; Gu A; Wu L; Liu X; Liang D
Biochem Biophys Res Commun; 2021 Mar; 545():40-45. PubMed ID: 33540285
[TBL] [Abstract][Full Text] [Related]
15. Generation of two genomic-integration-free DMD iPSC lines with mutations affecting all dystrophin isoforms and potentially amenable to exon-skipping.
Ferrari G; Muntoni F; Tedesco FS
Stem Cell Res; 2020 Mar; 43():101688. PubMed ID: 32087527
[TBL] [Abstract][Full Text] [Related]
16. Direct Reprogramming of Human DMD Fibroblasts into Myotubes for In Vitro Evaluation of Antisense-Mediated Exon Skipping and Exons 45-55 Skipping Accompanied by Rescue of Dystrophin Expression.
Lee JJA; Saito T; Duddy W; Takeda S; Yokota T
Methods Mol Biol; 2018; 1828():141-150. PubMed ID: 30171539
[TBL] [Abstract][Full Text] [Related]
17. Generation of three Duchenne Muscular Dystrophy patient-specific induced pluripotent stem cell lines DMD_YoTaz_PhyMedEXp, DMD_RaPer_PhyMedEXp, DMD_OuMen_PhyMedEXp (INSRMi008-A, INSRMi009-A and INSRMi010-A).
Souidi M; Amédro P; Meyer P; Desprat R; Lemaître JM; Rivier F; Lacampagne A; Meli AC
Stem Cell Res; 2020 Dec; 49():102094. PubMed ID: 33246213
[TBL] [Abstract][Full Text] [Related]
18. Generation of two induced pluripotent stem cell (iPSC) lines from patients with Duchenne muscular dystrophy (IGIBi006-A and IGIBi008-A) carrying exonic deletions in the dystrophin gene.
Ahmad I; Goel D; Ghosh A; Kapoor H; Kumar D; Ramesh K; Ashley B; Deepika K; Shastry A; Faruq M
Stem Cell Res; 2022 Oct; 64():102927. PubMed ID: 36191544
[TBL] [Abstract][Full Text] [Related]
19. Restoring Dystrophin Expression with Duchenne Muscular Dystrophy Exon 45 Skipping in Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
Sato M; Shiba N; Miyazaki D; Shiba Y; Nakamura A
Methods Mol Biol; 2023; 2587():141-151. PubMed ID: 36401028
[TBL] [Abstract][Full Text] [Related]
20. Precise correction of the dystrophin gene in duchenne muscular dystrophy patient induced pluripotent stem cells by TALEN and CRISPR-Cas9.
Li HL; Fujimoto N; Sasakawa N; Shirai S; Ohkame T; Sakuma T; Tanaka M; Amano N; Watanabe A; Sakurai H; Yamamoto T; Yamanaka S; Hotta A
Stem Cell Reports; 2015 Jan; 4(1):143-154. PubMed ID: 25434822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
